The debate surrounding the legalization and rescheduling of cannabis has been a hot topic in recent years. With more states...
The Department of Veteran Affairs (VA) has recently announced its decision to provide funding for studies on psilocybin and MDMA...
Insights from a Former DEA Official: Potential Implications for the Marijuana Industry Revealed As the marijuana industry continues to grow...
The Drug Enforcement Administration (DEA) recently issued a notice highlighting a significant surge in research quantities for substances such as...
The Drug Enforcement Administration (DEA) has recently halted the applications of 120 Georgia pharmacies to sell medical cannabis. This decision...
The Drug Enforcement Administration (DEA) has recently issued a warning to pharmacies in Georgia regarding the sale of low-THC marijuana...
The University of Utah, a renowned institution for medical research and education, has recently announced its plans to establish a...
Important Information: Class Action Lawsuit Pending Regarding the Medical Marijuana Program Connection In recent years, the use of medical marijuana...
Potential Issues That May Arise Despite DEA’s Rescheduling of Cannabis to Schedule 3 In recent years, there has been a...
Understanding the Implications of Cannabis Rescheduling and Trademarks In recent years, there has been a significant shift in the legal...
Title: The Attempt by a DEA Judge to Reschedule Cannabis 35 Years Ago: A Historic Turning Point Introduction: In the...
The Department of Health and Human Services (HHS) has recently urged the Drug Enforcement Administration (DEA) to reclassify cannabis as...
Misconceptions of the DEA Regarding the Ongoing Fentanyl Crisis The ongoing fentanyl crisis has become a significant public health concern...
